1. Home
  2. GMED vs MEDP Comparison

GMED vs MEDP Comparison

Compare GMED & MEDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GMED
  • MEDP
  • Stock Information
  • Founded
  • GMED 2003
  • MEDP 1992
  • Country
  • GMED United States
  • MEDP United States
  • Employees
  • GMED N/A
  • MEDP N/A
  • Industry
  • GMED Medical/Dental Instruments
  • MEDP Biotechnology: Commercial Physical & Biological Resarch
  • Sector
  • GMED Health Care
  • MEDP Health Care
  • Exchange
  • GMED Nasdaq
  • MEDP Nasdaq
  • Market Cap
  • GMED 11.2B
  • MEDP 11.7B
  • IPO Year
  • GMED 2012
  • MEDP 2016
  • Fundamental
  • Price
  • GMED $81.11
  • MEDP $311.80
  • Analyst Decision
  • GMED Buy
  • MEDP Buy
  • Analyst Count
  • GMED 14
  • MEDP 10
  • Target Price
  • GMED $86.15
  • MEDP $388.44
  • AVG Volume (30 Days)
  • GMED 1.0M
  • MEDP 442.3K
  • Earning Date
  • GMED 11-05-2024
  • MEDP 10-21-2024
  • Dividend Yield
  • GMED N/A
  • MEDP N/A
  • EPS Growth
  • GMED N/A
  • MEDP 33.84
  • EPS
  • GMED 0.67
  • MEDP 11.42
  • Revenue
  • GMED $2,478,596,000.00
  • MEDP $2,070,866,000.00
  • Revenue This Year
  • GMED $62.26
  • MEDP $14.01
  • Revenue Next Year
  • GMED $6.76
  • MEDP $5.86
  • P/E Ratio
  • GMED $120.85
  • MEDP $27.19
  • Revenue Growth
  • GMED 102.10
  • MEDP 16.24
  • 52 Week Low
  • GMED $44.02
  • MEDP $268.80
  • 52 Week High
  • GMED $84.87
  • MEDP $459.77
  • Technical
  • Relative Strength Index (RSI)
  • GMED 64.46
  • MEDP 40.35
  • Support Level
  • GMED $79.94
  • MEDP $356.36
  • Resistance Level
  • GMED $83.74
  • MEDP $366.98
  • Average True Range (ATR)
  • GMED 1.85
  • MEDP 12.77
  • MACD
  • GMED 0.38
  • MEDP 0.39
  • Stochastic Oscillator
  • GMED 67.47
  • MEDP 17.30

About GMED Globus Medical Inc.

Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include advanced computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States.

About MEDP Medpace Holdings Inc.

Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical-device firms. It also offers ancillary services such as bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has over 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati and its operations are principally based in the us, but it also operates in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.

Share on Social Networks: